Endocannabinoid hydrolases differentially distribute in platelets and red blood cells and are differentially released by thrombin.
暂无分享,去创建一个
[1] F. Pacitti,et al. Inverse correlation between plasma 2‐arachidonoylglycerol levels and subjective severity of depression , 2021, Human psychopharmacology.
[2] F. Mayoral,et al. Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants , 2019, Neuropharmacology.
[3] D. Barrett,et al. An Analysis of Endocannabinoid Concentrations and Mood Following Singing and Exercise in Healthy Volunteers , 2018, Front. Behav. Neurosci..
[4] Stephen P. H. Alexander,et al. n-3 polyunsaturated N-acylethanolamines are CB2 cannabinoid receptor-preferring endocannabinoids. , 2018, Biochimica et biophysica acta. Molecular and cell biology of lipids.
[5] N. DiPatrizio,et al. Plasma fatty acid ethanolamides are associated with postprandial triglycerides, ApoCIII, and ApoE in humans consuming a high-fructose corn syrup-sweetened beverage. , 2018, American journal of physiology. Endocrinology and metabolism.
[6] Stephen P. H. Alexander,et al. Cannabinoid ligands, receptors and enzymes: Pharmacological tools and therapeutic potential , 2018, Brain and neuroscience advances.
[7] G. Leoncini,et al. Activation of CaMKKβ/AMPKα pathway by 2‐AG in human platelets , 2018, Journal of cellular biochemistry.
[8] V. Trezza,et al. Human serum albumin: A modulator of cannabinoid drugs , 2017, IUBMB life.
[9] M. Kelly,et al. Cannabinoids in the Cardiovascular System. , 2017, Advances in pharmacology.
[10] Stephen P. H. Alexander,et al. The endocannabinoid system is altered in the post‐mortem prefrontal cortex of alcoholic subjects , 2014, Addiction biology.
[11] S. O'Sullivan,et al. Endocannabinoids and the Cardiovascular System in Health and Disease. , 2015, Handbook of experimental pharmacology.
[12] W. Siess,et al. Activation of platelets by the endocannabinoids 2-arachidonoylglycerol and virodhamine is mediated by their conversion to arachidonic acid and thromboxane A2, not by activation of cannabinoid receptors , 2014, Platelets.
[13] D. Tsikas,et al. Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects , 2014, Obesity.
[14] R. Florio,et al. The fatty acid amide hydrolase in lymphocytes from sedentary and active subjects. , 2014, Medicine and science in sports and exercise.
[15] G. Leoncini,et al. The 2-arachidonoylglycerol effect on myosin light chain phosphorylation in human platelets. , 2013, Biochimie.
[16] A. Poso,et al. Piperazine and piperidine triazole ureas as ultrapotent and highly selective inhibitors of monoacylglycerol lipase. , 2013, Chemistry & biology.
[17] J. Briegel,et al. Effect of an acute consumption of a moderate amount of ethanol on plasma endocannabinoid levels in humans. , 2012, Alcohol and alcoholism.
[18] M. Thiel,et al. Effects of exercise stress on the endocannabinoid system in humans under field conditions , 2011, European Journal of Applied Physiology.
[19] G. Leoncini,et al. Activation by 2‐arachidonoylglycerol of platelet p38MAPK/cPLA2 pathway , 2011, Journal of cellular biochemistry.
[20] Stephen P. H. Alexander,et al. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 , 2010, Pharmacological Reviews.
[21] C. Wainwright,et al. 2-arachidonyl glycerol activates platelets via conversion to arachidonic acid and not by direct activation of cannabinoid receptors. , 2010, British journal of clinical pharmacology.
[22] C. Tench,et al. Plasma endocannabinoid levels in multiple sclerosis , 2009, Journal of the Neurological Sciences.
[23] A. Finazzi-Agro’,et al. Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins. , 2009, Chemistry & biology.
[24] Raymond C Stevens,et al. Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. , 2009, Chemistry & biology.
[25] A. Siafaka-Kapadai,et al. Metabolism of 2-acylglycerol in rabbit and human platelets. Involvement of monoacylglycerol lipase and fatty acid amide hydrolase , 2009, Platelets.
[26] Benjamin F. Cravatt,et al. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects , 2008, Nature chemical biology.
[27] Sherry L. Niessen,et al. Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling. , 2008, Bioorganic & medicinal chemistry letters.
[28] M. Maccarrone,et al. The endocannabinoid 2‐arachidonoylglycerol activates human platelets through non‐CB1/CB2 receptors , 2008, Journal of thrombosis and haemostasis : JTH.
[29] Sandy J. Wilson,et al. Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase. , 2008, Bioorganic & medicinal chemistry letters.
[30] B. Cravatt,et al. A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2‐Arachidonoylglycerol , 2007, Chemistry & biology.
[31] F. Lang,et al. Effect of Anandamide on Erythrocyte Survival , 2007, Cellular Physiology and Biochemistry.
[32] R. Pertwee,et al. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2‐arachidonoylglycerol , 2004, British journal of pharmacology.
[33] P. Matarrese,et al. Morphological evidence that 2-arachidonoylglycerol is a true agonist of human platelets , 2004, Thrombosis and Haemostasis.
[34] Giovanni Piersanti,et al. Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies. , 2004, Journal of medicinal chemistry.
[35] H. Hansen,et al. Binding of anandamide to bovine serum albumin Published, JLR Papers in Press, July 1, 2003. DOI 10.1194/jlr.M300170-JLR200 , 2003, Journal of Lipid Research.
[36] A. Finazzi-Agro’,et al. Activation of human platelets by 2-arachidonoylglycerol is enhanced by serotonin , 2003, Thrombosis and Haemostasis.
[37] E. Duan,et al. Expression and regulation of the fatty acid amide hydrolase gene in the rat uterus during the estrous cycle and peri-implantation period. , 2002, Molecular human reproduction.
[38] B. Cravatt,et al. Transcriptional regulation of the mouse fatty acid amide hydrolase gene. , 2002, Gene.
[39] J. Casida,et al. Fatty acid amide hydrolase inhibition by neurotoxic organophosphorus pesticides. , 2001, Toxicology and applied pharmacology.
[40] C. Fowler,et al. Pharmacological properties of rat brain fatty acid amidohydrolase in different subcellular fractions using palmitoylethanolamide as substrate. , 2000, Biochemical pharmacology.
[41] M. Gelb,et al. Trifluoromethyl ketones and methyl fluorophosphonates as inhibitors of group IV and VI phospholipases A(2): structure-function studies with vesicle, micelle, and membrane assays. , 1999, Biochimica et biophysica acta.
[42] A. Finazzi Agro',et al. Anandamide activates human platelets through a pathway independent of the arachidonate cascade , 1999, FEBS letters.
[43] E. Dennis,et al. A specific human lysophospholipase: cDNA cloning, tissue distribution and kinetic characterization. , 1999, Biochimica et biophysica acta.
[44] D. Deutsch,et al. Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase. , 1997, Biochemical pharmacology.
[45] O. Nobili,et al. Purification and properties of a monoacylglycerol lipase in human erythrocytes. , 1995, The Biochemical journal.
[46] J. Boyer,et al. Increased monoester lipase activity in red blood cells in late pregnancy. , 1985, Acta Haematologica.
[47] P. Kinnunen,et al. Monoacylglycerol hydrolase in human platelets. , 1979, Biochimica et biophysica acta.
[48] A. Noma,et al. Purification of monoacylglycerol hydrolase from human post‐heparin plasma , 1976, FEBS letters.
[49] P. Nilsson-ehle,et al. A monoglyceride hydrolyzing enzyme in human postheparin plasma. , 1972, Biochimica et Biophysica Acta.
[50] R. Levy,et al. Evidence for separate monoglyceride hydrolase and triglyceride lipase in post-heparin human plasma. , 1969, Journal of lipid research.